Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000891092-19-004449
Filing Date
2019-04-10
Accepted
2019-04-10 16:07:39
Documents
1
Group Members
JEREMY MINDICHMATTHEW SIROVICHSCOPIA MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A e4682sc13ga.htm SC 13G/A 89084
  Complete submission text file 0000891092-19-004449.txt   91014
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Subject) CIK: 0000920465 (see all company filings)

EIN.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44849 | Film No.: 19741752
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

EIN.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A